0001628280-20-017744.txt : 20201223
0001628280-20-017744.hdr.sgml : 20201223
20201223182410
ACCESSION NUMBER: 0001628280-20-017744
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201222
FILED AS OF DATE: 20201223
DATE AS OF CHANGE: 20201223
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Evans Richard B. Jr.
CENTRAL INDEX KEY: 0001632641
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34746
FILM NUMBER: 201413896
MAIL ADDRESS:
STREET 1: C/O ACCRETIVE HEALTH, INC.
STREET 2: 401 N. MICHIGAN AVENUE, SUITE 2700
CITY: CHICAGO
STATE: IL
ZIP: 60611
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: R1 RCM INC.
CENTRAL INDEX KEY: 0001472595
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MANAGEMENT SERVICES [8741]
IRS NUMBER: 020698101
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 401 NORTH MICHIGAN AVENUE
STREET 2: SUITE 2700
CITY: CHICAGO
STATE: IL
ZIP: 60611
BUSINESS PHONE: 312-324-7820
MAIL ADDRESS:
STREET 1: 401 NORTH MICHIGAN AVENUE
STREET 2: SUITE 2700
CITY: CHICAGO
STATE: IL
ZIP: 60611
FORMER COMPANY:
FORMER CONFORMED NAME: Accretive Health, Inc.
DATE OF NAME CHANGE: 20090918
4
1
wf-form4_160876583729288.xml
FORM 4
X0306
4
2020-12-22
0
0001472595
R1 RCM INC.
RCM
0001632641
Evans Richard B. Jr.
C/O R1 RCM INC.
401 N. MICHIGAN AVE, SUITE 2700
CHICAGO
IL
60611
0
1
0
0
Principal Accounting Officer
Common Stock
2020-12-22
4
M
0
17743
0
A
73862
D
Common Stock
2020-12-22
4
M
0
185956
0
A
259818
D
Common Stock
2020-12-22
4
F
0
88275
23.43
D
171543
D
Performance-Based Restricted Stock Units
2020-12-22
4
M
0
17743
0
D
Common Stock
17743.0
0
D
Performance-Based Restricted Stock Units
2020-12-22
4
M
0
185956
0
D
Common Stock
185956.0
0
D
Represents shares of common stock received upon settlement of performance-based restricted stock units ("PBRSUs").
25% of the amount represents shares earned upon settlement of the PBRSUs, which remain subject to continued service by the reporting person through December 31, 2021. Refer to footnote 4 for further details.
Represents a contingent right to receive the Issuer's common stock.
On May 29, 2018, the reporting person was granted PBRSUs that were previously reported on Table II of Form 4 filed on May 31, 2018. Pursuant to the award agreement, the PBRSUs were subject to both a time-based vesting condition and a performance-based vesting condition based on an average per share price of the Issuer's common stock as defined in the award agreement, measured at December 22, 2020. At target, the PBRSUs covered 11,829 shares. Because the average price per share at the end of the performance period exceeded the maximum target of $14.00 per share, the reporting person earned the maximum number of shares, or 150% of the target award. The time-based vesting condition for 75% of the PBRSUs was satisfied on December 22, 2020. The time-based vesting condition for the remaining 25% of the PBRSUs may be satisfied on the earlier of December 31, 2021 and a qualifying change of control.
On August 28, 2017, the reporting person was granted PBRSUs that were previously reported on Table II of Form 4 filed on November 21, 2017. Pursuant to the award agreement, the PBRSUs were subject to both a time-based vesting condition and a performance-based vesting condition based upon an average per share price of the Issuer's common stock as defined in the award agreement, measured at December 22, 2020. At target, the PBRSUs covered 92,978 shares. Because the average price per share at the end of the performance period exceeded the maximum target of $9.00 per share, the reporting person earned the maximum number of shares, or 200% of the target award. The time-based vesting condition was fully satisfied on December 22, 2020.
/s/ E. Terry Platis, Attorney-in-Fact
2020-12-23